Coronary artery disease concomitant with chronic obstructive pulmonary disease.
about
Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in JapanAS-703026 Inhibits LPS-Induced TNFα Production through MEK/ERK Dependent and Independent Mechanisms.Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer.COPD disease severity and the risk of venous thromboembolic events: a matched case-control study.Impact of Chronic Obstructive Pulmonary Disease on Long-Term Outcome in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity.Lung Function Abnormalities in Smokers with Ischemic Heart Disease.Chronic Obstructive Pulmonary Disease and the Risk of Stroke.Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.A novel AMPK activator hernandezine inhibits LPS-induced TNFα production.miR-135b-5p inhibits LPS-induced TNFα production via silencing AMPK phosphatase Ppm1e.Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.Defining the relationship between COPD and CVD: what are the implications for clinical practice?Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease and long-term mortality in elderly subjects with chronic heart failure.Peripheral Artery Disease in Patients with Chronic Obstructive Pulmonary Disease.Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome.Coronary lesions in patients with COPD (Global Initiative for Obstructive Lung Disease stages I–III) and suspected or confirmed coronary arterial disease.Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity
P2860
Q34700758-35ED11B2-7DA4-416C-8874-CFA62D3CDAD0Q35779438-E3396124-A8BD-4816-B902-B4772D296720Q35897669-6030BA15-736E-4006-BA57-2AC48722B868Q36861849-89DA38E8-1277-46E1-9CB6-A090AAEDB828Q37500727-4A554095-7C07-4302-B712-832208615D6DQ38178003-384C8D73-E841-4D84-8A36-5D169C219556Q38839263-8403188B-F3FF-4D54-867F-FABA75AC8D74Q39268464-4091A766-8DD5-4A35-A996-2CBD2E895265Q40430108-A56D286C-7A79-4123-B35B-FC8278E55251Q41846937-EB111FB8-C210-4299-AB6E-D3ECD2E01885Q42314589-D3285FDB-0CB3-461E-BCC3-386F56655373Q46165199-A7F27680-F7DF-47DD-8B00-A833D10B7B40Q47651592-CB91BE71-3D44-4810-A5E7-752D0F2BA1F0Q47680491-47922607-F1D3-4481-B28F-F911CF6103FEQ47967985-5C92FF87-44DC-469F-9B27-17D5607A11EBQ49124502-55DC1568-CFB4-47C7-B0E4-C686B23FE8CDQ54940707-EA13FAA3-9C6E-499F-A992-8BC39893306EQ55428223-C5CF3556-DB9D-449A-9095-9C897624226DQ57092157-0122EBCF-3182-4E34-BE0F-29D957B0A27B
P2860
Coronary artery disease concomitant with chronic obstructive pulmonary disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Coronary artery disease concomitant with chronic obstructive pulmonary disease.
@en
type
label
Coronary artery disease concomitant with chronic obstructive pulmonary disease.
@en
prefLabel
Coronary artery disease concomitant with chronic obstructive pulmonary disease.
@en
P2093
P2860
P356
P1476
Coronary artery disease concomitant with chronic obstructive pulmonary disease.
@en
P2093
Giuseppe Spadafora
Pietro Roversi
Sara Roversi
P2860
P304
P356
10.1111/ECI.12181
P577
2013-10-26T00:00:00Z